Pinealon Nasal Spray for Laboratory Research
Pinealon nasal spray is a specialized laboratory reagent containing the synthetic tripeptide Glu-Asp-Arg, engineered for non-clinical research evaluating central nervous system peptide transport, neuronal chromatin interactions, and neuroprotective signaling pathways. Formulated to support consistent intranasal delivery in animal and cellular assays, this compound allows investigators to study peptide-driven biological response without systemic hepatic clearance.
Quick answer
Pinealon nasal spray is a specialized laboratory reagent containing the synthetic tripeptide Glu-Asp-Arg, engineered for non-clinical research evaluating central nervous system peptide transport, neuronal chromatin interactions, and neuroprotective signaling pathways. Formulated to support consistent intranasal delivery in animal and cellular assays, this compound allows investigators to study peptide-driven biological response without systemic hepatic clearance.
Key takeaways
- Pinealon nasal spray is an intranasal laboratory reagent containing the synthetic tripeptide Glu-Asp-Arg (glutamic acid-aspartic acid-arginine), prepared for preclinical models investigating central nervous system bioavailability, epigenetic modulation, and neuronal gene expression.
- Pinealon is a synthetic short-chain peptide composed of three amino acid residues: L-glutamic acid, L-aspartic acid, and L-arginine (H-Glu-Asp-Arg-OH).
- Preclinical investigations demonstrate that short tripeptides like Pinealon do not rely solely on classical membrane-bound receptor cascades.
- Systemic administration of hydrophilic tripeptides often results in rapid enzymatic cleavage by circulating peptidases and limited transport across the intact blood-brain barrier (BBB).
Pinealon Nasal Spray Overview & Direct Research Answer
Pinealon nasal spray is an intranasal laboratory reagent containing the synthetic tripeptide Glu-Asp-Arg (glutamic acid-aspartic acid-arginine), prepared for preclinical models investigating central nervous system bioavailability, epigenetic modulation, and neuronal gene expression. Designed to facilitate olfactory-pathway mucosal absorption in animal and cellular assays, this formulation enables researchers to study peptide-driven neuroprotection without systemic degradation.
In experimental models, short-chain peptide bioregulators like Pinealon exhibit direct nuclear translocation and sequence-specific chromatin binding. By bypassing the blood-brain barrier through targeted nasal mucosal delivery, researchers can observe localized central nervous system effects with precise volumetric dosing. Every lot distributed by PX1 Research undergoes strict analytical verification, including reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry, ensuring high chemical purity for rigorous scientific protocols.
Molecular Structure and Biochemical Characterization of Pinealon
Pinealon is a synthetic short-chain peptide composed of three amino acid residues: L-glutamic acid, L-aspartic acid, and L-arginine (H-Glu-Asp-Arg-OH). With a low molecular weight of approximately 388.38 g/mol, Pinealon belongs to the class of peptide bioregulators originally identified during investigations into tissue-specific peptide signaling in central nervous system structures.
The primary biochemical profile of Pinealon hinges on its acidic-basic residue sequence. The negative charges provided by the carboxylic acid side chains of glutamic and aspartic acid paired with the basic guanidino group of arginine create a distinct charge distribution. Preclinical literature indicates this specific spatial orientation permits the peptide to interact with the major and minor grooves of double-stranded DNA, influencing chromatin structure and localized transcriptional activity in neuronal cultures.
Preclinical Mechanisms: Chromatin Interactions and Epigenetic Regulation
Preclinical investigations demonstrate that short tripeptides like Pinealon do not rely solely on classical membrane-bound receptor cascades. Instead, cellular uptake studies suggest that Pinealon penetrates nuclear membranes via passive diffusion or receptor-independent endocytosis. Once inside the nucleus, the tripeptide binds directly to specific histone-DNA complexes, altering histone acetylation profiles and chromatin accessibility.
In vitro models evaluating oxidative stress in primary neuronal cultures have shown that Pinealon exposure correlates with an upregulation of endogenous antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). Furthermore, rodent assays suggest that Pinealon modulates apoptotic signaling pathways by regulating the ratio of Bcl-2 to Bax proteins, thereby stabilizing mitochondrial membrane potential during induced ischemic or excitotoxic stress conditions. Investigators exploring these signaling networks can review additional peptide data within the PX1 Research literature hub.
Intranasal Dynamics: Bypassing the Blood-Brain Barrier in Research Models
Systemic administration of hydrophilic tripeptides often results in rapid enzymatic cleavage by circulating peptidases and limited transport across the intact blood-brain barrier (BBB). Intranasal delivery routes serve as an essential investigative methodology in preclinical research, providing a direct transport pathway along the olfactory and trigeminal nerve pathways to the cerebrospinal fluid (CSF) and brain parenchyma.
When administered via controlled intranasal apparatus in rodent models, Pinealon rapidly diffuses through the olfactory epithelium into the perineural space. This mucosal route minimizes systemic exposure, hepatic first-pass metabolism, and peripheral degradation, yielding higher localized concentrations within cerebral tissues. Research teams studying synergistic neuroprotective compounds often compare single-agent formulations against dual-active matrices such as the DSIP / Pinealon Nasal Spray combination.
Comparative Analysis: Short-Chain Peptides and Bioregulatory Compounds
Within short-chain peptide research, Pinealon represents a targeted tripeptide focused on neuronal tissue regulation and oxidative stress modulation. To establish comparative baselines across different tissue targets and physiological mechanisms, laboratory investigators frequently evaluate Pinealon alongside other established synthetic peptides within the broader catalog of research peptides.
For example, while Pinealon targets neuronal gene expression, the tetrapeptide Epithalon bioregulatory peptide is primarily studied for its interaction with telomerase activity and pineal gland regulation. Similarly, the bioregulatory tripeptide Vesugen vascular tripeptide (Lys-Glu-Asp) is routinely analyzed in endothelial cell culture models to examine vascular wall integrity and microvascular circulation. Contrastingly, peptides like Delta Sleep-Inducing Peptide, available in specialized research options like the DSIP / Pinealon formulation, affect neuroendocrine sleep-wake circuitry and stress-response pathways. The following matrix illustrates key differences across these short-chain research peptides:
Solvent Systems, pH Stability, and Laboratory Handling
Pinealon nasal spray reagents require precise environmental controls to preserve peptide bond integrity and prevent premature hydrolysis or aggregation. Standard formulations are buffered in isotonic, phosphate-buffered saline (PBS) or sterile water adjusted to a physiological pH range of 6.4 to 7.2. Maintaining an optimal pH environment is critical for preserving the ionic ionization states of the arginine and dicarboxylic acid residues.
In laboratory settings, research solutions should be aliquoted into sterile, non-pyrogenic glass or high-density polypropylene spray vessels designed for micro-volumetric delivery. Exposure to repeated freeze-thaw cycles, elevated ambient temperatures, or direct ultraviolet light must be avoided, as these variables accelerate hydrolytic cleavage of the Glu-Asp peptide bond. For long-term analytical stability, unconstituted reference standards or stock solutions should be stored at -20°C or -80°C.
Analytical Rigor: RP-HPLC and Mass Spectrometry Quality Verification
To ensure experimental reproducibility, research compounds must meet strict purity and identity criteria prior to deployment in in vitro or animal models. PX1 Research subjects every batch of Pinealon to comprehensive analytical screening, rejecting any lot that fails to meet non-negotiable chemical metrics.
Purity is quantitatively determined using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) equipped with ultraviolet detection (typically at 214 nm and 254 nm). A sharp, single chromatographic peak indicates the absence of truncated peptide fragments or synthesis byproducts, confirming chromatographic purity exceeding 98%. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass (M+H)+ of the Glu-Asp-Arg peptide, verifying structural fidelity without isomer contamination.
Endotoxin Testing and Sterility Standards for Preclinical Assays
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in preclinical central nervous system research. Intranasal administration of reagents contaminated with endotoxins can trigger acute neuroinflammatory cascades, microglial activation, and altered cytokine expression, masking the true physiological effects of the peptide under investigation.
PX1 Research conducts quantitative Limulus Amebocyte Lysate (LAL) testing per USP <85> guidelines on all intranasal reagents. Batches are guaranteed to contain endotoxin levels well below strict non-pyrogenic thresholds (<0.05 EU/mg). This rigorous control ensures that observed biological responses in cellular and animal models are strictly attributable to the Pinealon research compound rather than exogenous pyrogenic contaminants.
USA Manufacturing Standards and Supply Chain Integrity
All research peptides offered by PX1 Research are manufactured in state-of-the-art, GMP-compliant synthesis facilities within the United States. Utilizing automated solid-phase peptide synthesis (SPPS) technology under controlled cleanroom conditions minimizes chemical impurities and batch-to-batch variability.
Following synthesis and purification, independent ISO 17025-accredited analytical laboratories evaluate every lot. A lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and endotoxin assay results is published for verification. For institutions requiring high-volume orders or dedicated multi-lot reservations, PX1 Research provides streamlined procurement services through our bulk lab account portal.
Fulfillment, Storage Protocols, and Expedited Dispatch
Maintaining compound integrity during transit is vital for reliable preclinical research. PX1 Research operates dual fulfillment hubs located in California and Arizona, designed to expedite order processing and reduce transit times across domestic and international research facilities.
Orders placed before cutoff times Monday through Friday are dispatched the same day under climate-monitored conditions. Upon receipt, laboratory personnel should inspect packaging integrity and immediately transfer liquid spray formulations to refrigerated storage (2°C to 8°C) for short-term evaluation, or -20°C for extended stability, maintaining consistent experimental controls throughout the study lifespan.
Frequently Asked Questions
What is pinealon nasal spray used for in laboratory research?
Pinealon nasal spray is used in preclinical laboratory research to evaluate central nervous system bioavailability, epigenetic chromatin modulation, neuronal gene expression, and cellular defense mechanisms against oxidative stress without systemic administration.
What is the molecular sequence of the Pinealon tripeptide?
Pinealon is composed of three amino acids: L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg). It has an approximate molecular weight of 388.38 g/mol.
Why is an intranasal delivery route preferred for Pinealon preclinical models?
Intranasal delivery allows researchers to bypass hepatic first-pass metabolism and transport peptides directly along the olfactory and trigeminal nerve pathways to the brain, facilitating central nervous system distribution in animal models.
How does PX1 Research verify the purity of Pinealon nasal spray?
Every lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity levels ≥98% and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular weight and structure.
What are the endotoxin limits for PX1 Research Pinealon nasal spray?
PX1 Research subjects all lot batches to quantitative LAL endotoxin testing per USP <85> standards, ensuring levels remain below <0.05 EU/mg to prevent non-specific inflammatory responses in experimental models.
How should Pinealon nasal spray solutions be stored in the lab?
Liquid intranasal solutions should be kept refrigerated at 2°C to 8°C for short-term active testing protocols. Unconstituted reference powders or long-term stock vials should be stored frozen at -20°C or -80°C away from light.
Can Pinealon be evaluated in combination with other bioregulatory peptides?
Yes, researchers frequently evaluate Pinealon alongside or in combination with other neuroendocrine and bioregulatory peptides, such as DSIP or Epithalon, to investigate comparative or additive neuroprotective mechanisms.
Is a Certificate of Analysis (COA) available for Pinealon nasal spray?
Yes, PX1 Research provides a lot-specific Certificate of Analysis with every purchase, detailing raw HPLC chromatograms, mass spectrum analytical data, and endotoxin assay results from ISO 17025 accredited labs.
Is Pinealon nasal spray intended for human consumption or clinical therapy?
No. Pinealon nasal spray is strictly supplied as a research-grade chemical reagent for in vitro and laboratory experimental investigation. It is not for human, clinical, or therapeutic use.
Where is PX1 Research Pinealon manufactured and shipped from?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day shipping available Monday through Friday.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.